Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

352 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment of Locally Advanced Merkel Cell Carcinoma-A Multi-Center Study.
Dudzisz-Sledz M, Sobczuk P, Kozak K, Switaj T, Kosela-Paterczyk H, Czarnecka AM, Falkowski S, Rogala P, Morysinski T, Spalek MJ, Zdzienicki M, Goryn T, Zietek M, Cybulska-Stopa B, Klek S, Kaminska-Winciorek G, Ziolkowska B, Szumera-Cieckiewicz A, Rutkowski P. Dudzisz-Sledz M, et al. Among authors: kozak k. Cancers (Basel). 2022 Jan 14;14(2):422. doi: 10.3390/cancers14020422. Cancers (Basel). 2022. PMID: 35053584 Free PMC article.
Gene expression profiling of peripheral blood cells: new insights into Ewing sarcoma biology and clinical applications.
Przybyl J, Kozak K, Kosela H, Falkowski S, Switaj T, Lugowska I, Szumera-Cieckiewicz A, Ptaszynski K, Grygalewicz B, Chechlinska M, Pienkowska-Grela B, Debiec-Rychter M, Siedlecki JA, Rutkowski P. Przybyl J, et al. Among authors: kozak k. Med Oncol. 2014 Aug;31(8):109. doi: 10.1007/s12032-014-0109-2. Epub 2014 Jul 10. Med Oncol. 2014. PMID: 25008066 Free PMC article.
Trametinib: a MEK inhibitor for management of metastatic melanoma.
Lugowska I, Koseła-Paterczyk H, Kozak K, Rutkowski P. Lugowska I, et al. Among authors: kozak k. Onco Targets Ther. 2015 Aug 25;8:2251-9. doi: 10.2147/OTT.S72951. eCollection 2015. Onco Targets Ther. 2015. PMID: 26347206 Free PMC article. Review.
[The long-term treatment outcomes of adult osteosarcoma].
Ługowska I, Pieńkowski A, Szumera-Ciećkiewicz A, Koseła-Paterczyk H, Teterycz P, Głogowski M, Kozak K, Klimczak A, Falkowski S, Rutkowski P. Ługowska I, et al. Among authors: kozak k. Pol Merkur Lekarski. 2017 Apr 21;42(250):158-164. Pol Merkur Lekarski. 2017. PMID: 28530214 Polish.
The analysis of the long-term outcomes of sorafenib therapy in routine practice in imatinib and sunitinib resistant gastrointestinal stromal tumors (GIST).
Rutkowski P, Jagielska B, Andrzejuk J, Bylina E, Lugowska I, Switaj T, Kosela-Paterczyk H, Kozak K, Falkowski S, Klimczak A. Rutkowski P, et al. Among authors: kozak k. Contemp Oncol (Pozn). 2017;21(4):285-289. doi: 10.5114/wo.2017.72393. Epub 2017 Dec 30. Contemp Oncol (Pozn). 2017. PMID: 29416434 Free PMC article.
High baseline neutrophil-to-lymphocyte ratio predicts worse outcome in patients with metastatic BRAF-positive melanoma treated with BRAF and MEK inhibitors.
Teterycz P, Jagodzińska-Mucha P, Cybulska-Stopa B, Mariuk-Jarema A, Kozak K, Koseła-Paterczyk H, Czarnecka AM, Rajczykowski M, Dziura R, Galus Ł, Mackiewicz J, Świtaj T, Klimczak A, Falkowski S, Suwiński R, Ziobro M, Ługowska I, Rutkowski P. Teterycz P, et al. Among authors: kozak k. Melanoma Res. 2018 Oct;28(5):435-441. doi: 10.1097/CMR.0000000000000461. Melanoma Res. 2018. PMID: 29782381
352 results